Earnings Ahead

CLDX - Celldex Therapeutics, Inc.

34.94 -0.4 -1.13

Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc.

About

Profile


Headquarters

Hampton, New Jersey, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

CLDX



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Celldex Non-GAAP EPS of -$0.59 misses by $0.17, revenue of $0.16M misses by $0.24M
  • Celldex begins dosing in mid-stage study of barzolvolimab for skin disorder
  • Celldex posts early-stage data to support dose-dependent effect of urticaria therapy
  • Celldex GAAP EPS of -$0.49 misses by $0.04, revenue of $0.17M misses by $0.39M
  • Celldex GAAP EPS of -$0.43 misses by $0.02, revenue of $0.33M misses by $0.84M
  • Celldex Q4 2021 Earnings Preview
  • Celldex posts preclinical data from CDX-585 PD-1/ILT4 bispecific antibody program
  • Celldex EPS misses by $0.09, misses on revenue
  • Celldex's CDX-0159 improves quality of life and reduced disease impact in urticaria patients
  • Celldex EPS beats by $0.06, beats on revenue
  • Celldex rises with bullish call from Guggenheim; potential of lead asset cited
  • Celldex Therapeutics raises $250M via equity offering
  • Celldex Therapeutics proposes $175M capital raise
  • Tempest Therapeutics, Xtant Medical leads healthcare gainers; Sigilon Therapeutics, TransMedics among major losers
  • Animal health ratings change at Guggenheim; Celldex up with positive views on trial data - today’s analyst action
  • Celldex gains over a third on early-stage data for CDX-0159 in skin condition
  • Bionano Genomics to join Russell 3000 Index, while AcelRx Pharmaceuticals to see deletion among healthcare stocks
  • Celldex EPS misses by $0.08, misses on revenue
  • Celldex EPS misses by $0.18, beats on revenue
  • Celldex reports 80% complete response rate in CDX-0159 study in skin allergy

Earnings History

Date EPS / Forecast Revenue / Forecast
November 9, 2021 -0.45 / -0.355 153K / 1.22M Beat!
August 5, 2021 -0.34 / -0.4 3.48M / 643.33K
May 6, 2021 -0.42 / -0.345 685K / 965K
March 29, 2021 -0.55 / -0.3667 3.79M / 600K
November 5, 2020 -0.36 / -0.36 668K / 395K Beat!
August 6, 2020 -0.5 / -0.58 236K / 800K
May 6, 2020 -0.73 / -0.71 2.73M / 990K
March 26, 2020 -0.64 / -0.9 887K / 815K Beat!
November 12, 2019 -0.75 / -0.96 546K / 1.26M Beat!
Date Price Open High Low Vol Change
Jan 29 25.51 24.53
26.13
24.27
975K 3.61%
Jan 28 24.62 24.58
24.97
24.07
688K 0.33%
Jan 27 24.54 24.12
25.12
23.83
957K 2.16%
Jan 24 24.02 24.47
24.57
23.8
631K -1.6%
Jan 23 24.41 23.93
24.58
23.55
665K 0.70%
 
Jan 22 24.24 24.57
24.83
24.05
527K -1.5%
Jan 21 24.61 23.95
24.91
23.7
914K 3.49%
Jan 17 23.78 23.01
23.97
22.59
855K 4.48%
Jan 16 22.76 22.62
22.95
22.17
1.1M 0.62%
Jan 15 22.62 23.6
23.87
22.47
1.3M -1.39%
Jan 14 22.94 24.62
24.91
22.88
1.4M -5.67%
Jan 13 24.32 24.26
25
22.91
1.6M -0.12%
Jan 10 24.35 25.74
26.28
24.03
1.2M -8.22%
Jan 8 26.53 28.75
29.05
25.81
1.9M -3.88%
Jan 7 27.6 26.54
28.88
26.54
1.3M 3.84%
Jan 6 26.58 26.93
27.17
26.4
1.5M -0.86%
Jan 3 26.81 25.9
27.05
25.79
1.3M 3.96%
Jan 2 25.79 25.54
26.6
25.23
868K 2.06%
Dec 31, 2024 25.27 25.36
25.88
24.55
449K 0.60%
Dec 30, 2024 25.12 25.14
25.41
24.65
392K -1.06%
Dec 27, 2024 25.39 25.51
25.83
24.8
739K -1.01%
Dec 26, 2024 25.65 24.88
25.83
24.64
385K 2.07%
Dec 24, 2024 25.13 24.71
25.19
24.44
265K 1.45%
Dec 23, 2024 24.77 24.9
25.39
24.14
1.7M -1.47%
Dec 20, 2024 25.14 25.18
25.95
24.83
2.2M -0.95%
Dec 19, 2024 25.38 24.81
25.46
23.94
847K 2.26%
Dec 18, 2024 24.82 26.24
26.24
24.34
690K -4.69%
Dec 17, 2024 26.04 26
26.47
25.69
705K -0.61%
Dec 16, 2024 26.2 25.41
26.66
25
755K 3.11%
Dec 13, 2024 25.41 26.26
26.62
24.48
1.0M -3.93%
Dec 12, 2024 26.45 26.78
27.16
26.2
820K -2.07%
Dec 11, 2024 27.01 26.58
27.23
26.01
1.1M 1.89%
Dec 10, 2024 26.51 26.59
27.11
26.33
1.0M 0.42%
Dec 9, 2024 26.4 27.11
27.74
26.1
1.7M -1.38%
Dec 6, 2024 26.77 26.34
27.1
26
1.5M 2.72%
Dec 5, 2024 26.06 26.32
26.88
25.9
584K -1.96%
Dec 4, 2024 26.58 26.28
28.65
26.19
731K 1.37%
Dec 3, 2024 26.22 27.08
27.17
26.19
354K -3.71%
Dec 2, 2024 27.23 27.3
27.51
26.81
1.1M -0.77%
Nov 29, 2024 27.44 27.82
27.82
27.02
340K -1.61%
Nov 27, 2024 27.89 26.99
28.19
26.94
767K 4.22%
Nov 26, 2024 26.76 27.89
28.33
26.53
3.3M -4.9%
Nov 25, 2024 28.14 27.88
28.4
27.34
947K 4.15%
Nov 22, 2024 27.02 26.33
27.14
26
691K 3.05%
Nov 21, 2024 26.22 26.6
27.09
26.19
720K -0.68%
Nov 20, 2024 26.4 25
26.78
25
1.1M 5.68%
Nov 19, 2024 24.98 23.25
25.63
23.25
1.0M 7.16%
Nov 18, 2024 23.31 23.62
23.76
22.93
957K -1.02%
Nov 15, 2024 23.55 25.89
25.89
23.49
1.2M -8.51%
Nov 14, 2024 25.74 26.72
27.12
25.44
866K -4.1%
Nov 13, 2024 26.84 27.16
28.15
26.77
832K -0.63%
Nov 12, 2024 27.01 26.7
27.9
26.31
1.1M 3.05%
Nov 11, 2024 26.21 26.82
26.82
25.56
1.1M -0.04%
Nov 8, 2024 26.22 26.53
27
25.84
1.3M -0.94%
Nov 7, 2024 26.47 28
28.13
25.73
856K -4.2%
Nov 6, 2024 27.63 26
28.11
24.87
1.7M 8.65%
Nov 5, 2024 25.43 25.34
25.72
24.43
1.3M 0.16%
Nov 4, 2024 25.39 25.6
25.83
25.09
1.1M -1.13%
Nov 1, 2024 25.68 25.91
26.88
25.29
1.1M -1.46%
Oct 31, 2024 26.06 26.11
26.36
25.67
1.6M 0%